竞争风险模型预测子痫前期
本文综述一种基于竞争风险模型的新方法,通过母体人口学特征、病史及生物标志物计算患者特异性子痫前期风险。该方法可动态更新风险,用于早孕期识别高危人群以给予预防性干预,中孕期分层监测,以及对有高血压疾病症状者的个性化监测。
要点
- 竞争风险模型可计算任意孕周前发生子痫前期的患者特异性风险。
- 早孕期模型用于识别可从预防性治疗干预中获益的高危人群。
- 中孕期模型可将人群分层为高、中、低风险以确定监测强度。
核心结论
- 竞争风险模型可估计患者特异性子痫前期风险,并随生物标志物数据更新实现动态预测。
- 该模型可用于不同孕期的精准医学和风险分层。
研究设计与样本
- 综述,描述基于贝叶斯定理的竞争风险模型,结合母体因素与生物标志物进行子痫前期风险预测。
主要发现
- 每位孕妇均有子痫前期分娩孕周的个性化分布,是否在指定孕周前发生子痫前期取决于分娩与子痫前期发生之间的竞争。
- 将母体因素确定的先验分布与生物标志物似然度通过贝叶斯定理结合,新数据作为后验概率再充当先验,实现动态预测。
- 早孕期模型已用于识别可从预防性治疗干预中获益的高危人群。
- 中孕期模型已将人群分层为高、中、低风险组,以确定不同强度的后续监测。
- 该模型还可用于专科门诊中有高血压疾病症状者的监测,结合母体因素与生物标志物提供患者特异性风险,每次就诊更新风险。
临床怎么用
- 早孕期可使用竞争风险模型识别高危人群以给予预防性治疗干预。
- 中孕期可使用该模型将人群分层为高、中、低风险组,确定不同监测强度。
- 对出现高血压疾病症状的妇女,可结合母体因素与生物标志物计算患者特异性风险,实现个性化监测并在每次就诊时更新风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The established method of the assessment of the risk for development of preeclampsia is to identify risk factors from maternal demographic characteristics and medical history; in the presence of such factors, the patient is classified as high risk and in their absence as low risk. Although this approach is simple to perform, it has poor performance of the prediction of preeclampsia and does not provide patient-specific risks. This review describes a new approach that allows the estimation of patient-specific risks of delivery with preeclampsia before any specified gestational age by maternal demographic characteristics and medical history with biomarkers obtained either individually or in combination at any stage in pregnancy. In the competing risks approach, every woman has a personalized distribution of gestational age at delivery with preeclampsia; whether she experiences preeclampsia or not before a specified gestational age depends on competition between delivery before or after the development of preeclampsia. The personalized distribution comes from the application of Bayes theorem to combine a previous distribution, which is determined from maternal factors, with likelihoods from biomarkers. As new data become available, what were posterior probabilities take the role as the previous probability, and data collected at different stages are combined by repeating the application of Bayes theorem to form a new posterior at each stage, which allows for dynamic prediction of preeclampsia. The competing risk model can be used for precision medicine and risk stratification at different stages of pregnancy. In the first trimester, the model has been applied to identify a high-risk group that would benefit from preventative therapeutic interventions. In the second trimester, the model has been used to stratify the population into high-, intermediate-, and low-risk groups in need of different intensities of subsequent monitoring, thereby minimizing unexpected adverse perinatal events. The competing risks model can also be used in surveillance of women presenting to specialist clinics with signs or symptoms of hypertensive disorders; combination of maternal factors and biomarkers provide patient-specific risks for preeclampsia that lead to personalized stratification of the intensity of monitoring, with risks updated on each visit on the basis of biomarker measurements.
引用
- Wright D, Wright A, Nicolaides KH, et al. The competing risk approach for prediction of preeclampsia. Am J Obstet Gynecol. 2019. PMID: 31733203. doi:10.1016/j.ajog.2019.11.1247
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。